Benefit of drugs in post convulsion distress after Electro convulsive therapy

Effectiveness of Pretreatment Administration of Dexmedetomidine and Fentanyl for Post ICTAL Agitation after Electroconvulsive Therapy - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082682

Enrollment

Registered

2025-03-19

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G- Mental Health

Interventions

Intervention1: Dexmedetomidine: Standard anaesthesia protocol will be followed and patients will be premedicated with IV Glycopyrrolate 0.2mg, Ondansetron 4mg and dexmedetomidine 0.5mcg/kg body weight

Eligibility

Inclusion criteria

Inclusion criteria: ASA Grade 1 & 2,pt with major psychiatric disorder

Exclusion criteria

Exclusion criteria: patient & attender refusal,risk of aspiration,cardivascular disease,neuromascular disease,pt with implants,pregnancy,drug allergy,active respiratory diseases

Design outcomes

Primary

Measure	Time frame
To determine the efficacy of Dexmedetomidine & Fentanyl for attenuation of post ictal agitation after ECTTimepoint: hemodynamic parameters at 5,10,15,30,45 mins after ECT	—

Secondary

Measure	Time frame
role of Dexmedetomidine & Fentanyl in hemodynamic responses & recovery time after ECTTimepoint: at 5,10,15,30,45 mins	—

Countries

India

Contacts

Public ContactDr Sweyta Shrivastava

Gandhi Medical College

yashwantdhawalegmc@gmail.com9425667373

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026